Glycated Albumin as a Predictor of Adverse Outcomes in Patients Undergoing Primary Total Hip and Knee Arthroplasty: A Multicenter Prospective Study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTarabichi, Saad
dc.contributor.authorAbe, Elizabeth A.
dc.contributor.authorOlin, Brooke
dc.contributor.authorLizcano, Juan D.
dc.contributor.authorGoh, Graham S.
dc.contributor.authorMu, Wenbo
dc.contributor.authorHozack, William J.
dc.contributor.authorCao, Li
dc.contributor.authorParvizi, Javad
dc.contributor.authorCourtney, P. Maxwell
dc.date.accessioned2025-10-16T15:11:32Z
dc.date.issued2025
dc.identifier.doi10.1016/j.arth.2025.04.061
dc.identifier.otherWOS:001573879600028
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/4774
dc.publisherCHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
dc.sourceJOURNAL OF ARTHROPLASTY
dc.subjectglycemic control
dc.subjecttotal joint arthroplasty
dc.subject90\\-day complications
dc.subjectglycated albumin
dc.subjectfructosamine
dc.subjectglycated hemoglobin
dc.titleGlycated Albumin as a Predictor of Adverse Outcomes in Patients Undergoing Primary Total Hip and Knee Arthroplasty: A Multicenter Prospective Study
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS